All Type of News
The emergence of a new treatment, which broke the one-year barrier of the survival period of cancer patients
A lung cancer treatment, which extended the survivalperiod of inexperienced patients to an epoch-making time, will enter the Korean market.
The product has received attention because it broke the one-year barrier in ...
After the president election of the Korea Pharmaceutical Distribution Association, it is inevitable to have conflicts with the pharmaceutical industry
After the president election of the Korea PharmaceuticalDistribution Association (KPDA), conflicts between the wholesale and pharmaceutical industry are expected to be inevitable.
The KPDA will hold a regular general...
Pfizer Korea and Jaeil Pharmaceutical has made the joint promotion agreement for ‘Celebrex’
Pfizer Korea (CEO Dong-soo Lee) and Jaeil Pharmaceutical (CEO Suk-jae Sung) held the joint promotion agreement ceremony andstrategy workshop for‘Celebrex (generic name: celecoxib)’ on the last 9th.
Under the joint pr...
What are the blockbuster-level generics in 2015?
As a series of blockbuster-level pharmaceutical products is about to be expired this year, competitions between‘keepers (pharmaceutical companies)’ and ‘getters(pharmaceutical companies)’ will get even fiercer.
Pharm...
The Ministry of Food and Drug Safety started to re-collect difficulties of the Korea-China FTA non-tariff barrier
The Ministry of Food and Drug Safety started to re-collect difficulties of the pharmaceutical industry on exporting to China due to the so-called ‘invisible barrier’.
Under the Korea-China FTA (Free Trade Agreement),...
Would it different from Vioxx? The challenge of the COX-2 inhibitor, Arcoxia, will beginMSD has challenged the COX-2 inhibitor market again. However, it is analyzed that the expected result for the new challenge would not be different from the old one.
The Ministr...
|
Due to the increasing number of psoriasis patients, the psoriasis treatment market is heating up
As psoriasis patients increases, the psoriasis treatment market is also getting heated up.
According to the analysis result of medical expenses provided by the National Health Insurance from 2009 to 2013, the Nationa...
“The Chinese unethical business custom will be an obstacle of entry for domestic pharmaceutical companies”
It is analyzed that unethical business customs in the pharmaceutical industry in China would be amajor obstacle for domestic pharmaceutical companies to enter in the non-tariff field.
Since many multinational pharmac...
Domestic pharmaceutical companies have failed on the patent nullity of Baraclude
As Daewoong Pharmaceutical and Hanmi Pharmaceutical have failed on the substance patent nullity of Baraclude, domestic pharmaceutical companies’ exclusive sale rights have also been blown away, too.
If the substance ...
Medical equipment sales for oriental doctors have begun… what is the hidden opinion of the healthcare industry?
What would be the common opinion of the healthcare industry on the use of modern medical equipment for oriental doctors?
The Office for Government Policy Coordination held the Guillotine Private and Public Meeting pa...
